Comments
Loading...
Latest 4D Molecular Therapeutics Stock News | NASDAQ:FDMT | Benzinga
Get the latest news on 4D Molecular Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on 4D Molecular Therapeutics performance
Categories: All
Monday, March 10, 2025
Tuesday, March 04, 2025
Monday, March 03, 2025
Friday, February 28, 2025
Tuesday, February 11, 2025
Monday, February 10, 2025
Monday, January 13, 2025
Friday, January 10, 2025
Wednesday, December 18, 2024
Monday, December 16, 2024
Thursday, November 21, 2024
Thursday, November 14, 2024
Wednesday, November 13, 2024
Monday, September 23, 2024
Thursday, September 19, 2024
- 4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate
- Chardan Capital Maintains Buy on 4D Molecular...
- 4D Molecular Therapeutics shares are trading ...
- Leerink Partners Reiterates Outperform on 4D ...
- HC Wainwright & Co. Reiterates Buy on 4D Mole...
Wednesday, September 18, 2024
Monday, September 09, 2024
Friday, August 09, 2024
Thursday, August 08, 2024
Monday, July 22, 2024
Thursday, July 18, 2024
Wednesday, July 17, 2024
- 4DMT shares are trading lower. The company an...
- Chardan Capital Maintains Buy on 4D Molecular...
- 4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate
- Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- 4D Molecular Therapeutics Presents Phase 2 Tr...